Dolby Laboratories, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 28, 2025: 27.91%

Dolby Laboratories, Inc. EBITDA Margin is 27.91% for the Trailing 12 Months (TTM) ending March 28, 2025, a -3.57% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • Dolby Laboratories, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 29, 2024 was 28.95%.
  • Dolby Laboratories, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending April 01, 2022 was 25.37%, a -21.48% change year over year.
  • Dolby Laboratories, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 26, 2021 was 32.31%, a 4.49% change year over year.
Key Data
Date EBITDA Margin Net Income Margin EBT Margin Operating Income Margin